Kohrt named to new post at Kodak

Article

Carl Kohrt, vice president and general manager of Eastman Kodak'sHealth Sciences division, has found himself in privileged companyat the Rochester, NY, film giant. Kohrt joined chief executiveGeorge Fisher as one of three executives named to a new

Carl Kohrt, vice president and general manager of Eastman Kodak'sHealth Sciences division, has found himself in privileged companyat the Rochester, NY, film giant. Kohrt joined chief executiveGeorge Fisher as one of three executives named to a new chiefoperating office designed be the nucleus of Kodak's senior managementteam.

In announcing the moves last week, Fisher said the new teamwould handle the day-to-day operations of Kodak's global business.All the business, manufacturing, R&D and geographic regionsthat previously reported to other executives will report to thenew office. Kohrt will remain head of the Health Sciences unit.

Fisher will add COO to his titles of chairman, president andCEO, while Kohrt adds executive vice president and assistant COOto his resume. Joining Fisher and Kohrt on the team is DanielCarp, vice president and general manager of Kodak's European,African and Middle Eastern region.

Kodak said the moves were being made to strengthen the nextgeneration of Kodak's management team, making Kohrt and Carp automaticfront-runners in the event Fisher leaves the company.

Fisher was named to lead Kodak in 1993 and has dramaticallyincreased the company's focus on digital imaging (SCAN 4/12/94).He has said he intends to remain with the company at least throughhis current contract, which runs until 1998.

Kohrt, a 24-year Kodak veteran who has headed Health Sciencesfor four years, has led the division to increased worldwide marketshare despite an era of dramatic change and consolidation, Fishersaid.

"Carl Kohrt has defined Kodak's leadership in one of themost challenging markets in the world today, health care,"Fisher said.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.